Evercore ISI analyst Robert Ottenstein lowered the firm’s price target on Colgate-Palmolive (CL) to $94 from $100 and keeps an Outperform rating on the shares. Trading at a 20-year low relative to Staples, Colgate is “currently oversold,” but showing resilience by modestly outperforming the sector despite a recent sales miss, the analyst tells investors in a post-earnings note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target lowered to $87 from $96 at Morgan Stanley
- Colgate-Palmolive price target lowered to $95 from $105 at Citi
- Colgate-Palmolive price target lowered to $77 from $80 at Wells Fargo
- Midday Fly By: Apple, Amazon upbeat reports lift Nasdaq
- Morning Movers: Brighthouse Financial surges after take-private deal report